Detalhe da pesquisa
1.
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.
Genes Dev
; 25(23): 2465-79, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156207
2.
A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.
J Biol Inorg Chem
; 23(3): 399-411, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508136
3.
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis.
Nat Cancer
; 2(10): 1086-1101, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121879
4.
Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma In Vivo and Display No Significant Systemic Toxicity.
ACS Pharmacol Transl Sci
; 3(4): 644-654, 2020 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32832867
5.
Water Soluble Phosphane-Gold(I) Complexes. Applications as Recyclable Catalysts in a Three-component Coupling Reaction and as Antimicrobial and Anticancer Agents.
Eur J Inorg Chem
; 2009(23): 3421-3430, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23524957
6.
Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.
Cancer Med
; 8(9): 4304-4314, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192543
7.
Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer.
Eur J Med Chem
; 161: 310-322, 2019 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30368130
8.
Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents.
Chem Commun (Camb)
; 52(15): 3155-8, 2016 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26804743
9.
Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes.
Dalton Trans
; 45(16): 7049-66, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26990859
10.
Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro.
Organometallics
; 35(9): 1218-1227, 2016 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27182101
11.
Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.
J Inorg Biochem
; 156: 22-34, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26717259
12.
Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo.
Chem Sci
; 6(9): 5269-5283, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213034
13.
Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties.
Organometallics
; 33(22): 6669-6681, 2014 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25435644
14.
In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer.
J Med Chem
; 57(23): 9995-10012, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409416
15.
Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.
Nat Cell Biol
; 16(9): 876-88, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25086747